DOI QR코드

DOI QR Code

Comparison of the Efficacy between the Single-Dose and Three-Day Prophylactic Antibiotic Regimens for the Prevention of Bacterial Infections in Patients with Percutaneous Nephrolithotomy: A Randomized Controlled Study

  • Chae, Han Kyu (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Myong (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin, Jung Hyun (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Hyung Keun (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2018.08.09
  • Accepted : 2018.09.13
  • Published : 2018.12.31

Abstract

Purpose: To determine the appropriate regimen of antibiotic prophylaxis for the prevention of bacterial infections in patients receiving percutaneous nephrolithotomy (PCNL). Materials and Methods: Forty patients, who planned to undergo PCNL from October 2015 to August 2017, were assigned randomly into two groups. Patients in the single-dose group (n=20) were administered an intravenous single dose of 2 g ceftriaxone 30 minutes before PCNL, whereas those in the three-days regimen group (n=20) were administered a preoperative intravenous single dose of 2 g ceftriaxone and an additional postoperative oral cefpodoxime proxetil (100 mg twice a day) for three days. The incidences of infectious complications in the two groups, such as pyrexia, systemic inflammatory response syndrome (SIRS), and sepsis, were compared. Results: Fever (axillary temperature >$38.0^{\circ}C$) did not develop in any of the patients in the single-dose group but developed in one patient (5.0%) in the three-day regimen group due to pneumonia (p=0.3). SIRS developed in a total of eight patients (20.0%), four patients from each group. None of the patients in either group developed sepsis after PCNL. Conclusions: The three-day prophylactic antibiotic regimen did not demonstrate better efficacy for the prevention of bacterial infections in patients with PCNL compared to the single-dose prophylactic antibiotic regimen.

Keywords

References

  1. Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol 2016;69:475-82. https://doi.org/10.1016/j.eururo.2015.07.041
  2. Tyson MD 2nd, Humphreys MR. Postoperative complications after percutaneous nephrolithotomy: a contemporary analysis by insurance status in the United States. J Endourol 2014;28:291-7. https://doi.org/10.1089/end.2013.0624
  3. Singh P, Yadav S, Singh A, Saini AK, Kumar R, Seth A, et al. Systemic inflammatory response syndrome following percutaneous nephrolithotomy: assessment of risk factors and their impact on patient outcomes. Urol Int 2016;96:207-11. https://doi.org/10.1159/000441954
  4. Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ; Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179:1379-90. https://doi.org/10.1016/j.juro.2008.01.068
  5. Cadeddu JA, Chen R, Bishoff J, Micali S, Kumar A, Moore RG, et al. Clinical significance of fever after percutaneous nephrolithotomy. Urology 1998;52:48-50. https://doi.org/10.1016/S0090-4295(98)00146-0
  6. Shim M, Park M, Park HK. Effects of continuous peritubal local anesthetic instillation on postoperative pain after percutaneous nephrolithotomy: a prospective, randomized three-arm study. J Endourol 2016;30:504-9. https://doi.org/10.1089/end.2015.0847
  7. Tom WR, Wollin DA, Jiang R, Radvak D, Simmons WN, Preminger GM, et al. Next-generation single-use ureteroscopes: an in vitro comparison. J Endourol 2017;31:1301-6. https://doi.org/10.1089/end.2017.0447
  8. Turck M, Stamm W. Nosocomial infection of the urinary tract. Am J Med 1981;70:651-4. https://doi.org/10.1016/0002-9343(81)90590-8
  9. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100. https://doi.org/10.1053/jinf.2002.1091
  10. Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ 2016;352:i939.
  11. Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 2014;139:945-8.
  12. Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, et al. The emerging threat of multidrugresistant Gram-negative bacteria in urology. Nat Rev Urol 2015;12:570-84. https://doi.org/10.1038/nrurol.2015.199
  13. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013;190:222-7. https://doi.org/10.1016/j.juro.2013.01.069
  14. Bag S, Kumar S, Taneja N, Sharma V, Mandal AK, Singh SK. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. Urology 2011;77:45-9. https://doi.org/10.1016/j.urology.2010.03.025
  15. Demirtas A, Yildirim YE, Sofikerim M, Kaya EG, Akinsal EC, Tombul ST, et al. Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study. ScientificWorldJournal 2012;2012:916381.
  16. Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol 2002;16:649-53. https://doi.org/10.1089/089277902761402989
  17. Lai WS, Assimos D. The role of antibiotic prophylaxis in percutaneous nephrolithotomy. Rev Urol 2016;18:10-4.
  18. Chew BH, Miller NL, Abbott JE, Lange D, Humphreys MR, Pais VM Jr, et al. A randomized controlled trial of preoperative prophylactic antibiotics prior to percutaneous nephrolithotomy in a low infectious risk population: a report from the EDGE consortium. J Urol 2018;200:801-8. https://doi.org/10.1016/j.juro.2018.04.062
  19. Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim SW, et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect 2010;60:146-53. https://doi.org/10.1016/j.jinf.2009.11.004